346 related articles for article (PubMed ID: 17956258)
1. Protein-protein interactions in the assembly and subcellular trafficking of the BACE (beta-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease.
Parsons RB; Austen BM
Biochem Soc Trans; 2007 Nov; 35(Pt 5):974-9. PubMed ID: 17956258
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the lipidation of beta-secretase by statins.
Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM
Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
[TBL] [Abstract][Full Text] [Related]
3. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
4. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
Tanahashi H; Tabira T
Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
[TBL] [Abstract][Full Text] [Related]
5. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
7. Protein lipidation of BACE.
Parsons RB; Austen BM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1091-3. PubMed ID: 16246052
[TBL] [Abstract][Full Text] [Related]
8. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
Sauder JM; Arthur JW; Dunbrack RL
J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463
[TBL] [Abstract][Full Text] [Related]
9. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Hook VY; Reisine TD
J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
[TBL] [Abstract][Full Text] [Related]
10. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
11. BACE: Therapeutic target and potential biomarker for Alzheimer's disease.
Evin G; Barakat A; Masters CL
Int J Biochem Cell Biol; 2010 Dec; 42(12):1923-6. PubMed ID: 20817005
[TBL] [Abstract][Full Text] [Related]
12. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
Fu H; Li W; Luo J; Lee NT; Li M; Tsim KW; Pang Y; Youdim MB; Han Y
Biochem Biophys Res Commun; 2008 Feb; 366(3):631-6. PubMed ID: 18039469
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
Vassar R
Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
[No Abstract] [Full Text] [Related]
16. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
Wozniak MA; Itzhaki RF; Shipley SJ; Dobson CB
Neurosci Lett; 2007 Dec; 429(2-3):95-100. PubMed ID: 17980964
[TBL] [Abstract][Full Text] [Related]
17. Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.
Tan J; Evin G
J Neurochem; 2012 Mar; 120(6):869-80. PubMed ID: 22171895
[TBL] [Abstract][Full Text] [Related]
18. Progress toward the discovery and development of efficacious BACE inhibitors.
Durham TB; Shepherd TA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
[TBL] [Abstract][Full Text] [Related]
19. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.
Kinoshita A; Fukumoto H; Shah T; Whelan CM; Irizarry MC; Hyman BT
J Cell Sci; 2003 Aug; 116(Pt 16):3339-46. PubMed ID: 12829747
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G
Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
